Scinovex
article Open AccessTop 1% cited

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

BMC Cancer · 2011 · Vol. 11(1) · pp. 20–20
Meei-Shyuan LeeChih-Cheng HsuMark L. WahlqvistHsin-Ni TsaiYu‐Hung ChangYi-Chen Huang

Abstract

Metformin can reduce the incidences of several gastroenterological cancers in treated diabetes.

Metabolism, Diabetes, and CancerDiet and metabolism studiesDiet, Metabolism, and DiseaseMedicineMetforminType 2 diabetesColorectal cancerSurgical oncologyPancreatic cancerProspective cohort studyInternal medicineDiabetes mellitusOncology

MeSH terms

AdultAgedDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsLiver NeoplasmsMaleMetforminMiddle AgedPancreatic NeoplasmsProspective StudiesRegistriesSex FactorsTaiwan

Funding

  • National Health Research Institutes
Citations
463
FWCI
20.49
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Cited by
Metformin as a Tool to Target Aging
Cell Metabolism · 2016 · 1,015 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.